The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Atsuo Tahara

Institute for Drug Discovery Research

Yamanouchi Pharmaceutical Co. Ltd

Ibaraki

Japan

[email]@yamanouchi.co.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd, Ibaraki, Japan. 1998 - 2005

References

  1. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors. Tahara, A., Tsukada, J., Tomura, Y., Kusayama, T., Wada, K., Ishii, N., Taniguchi, N., Suzuki, T., Yatsu, T., Uchida, W., Shibasaki, M. Pharmacol. Res. (2005) [Pubmed]
  2. Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats. Tahara, A., Tsukada, J., Tomura, Y., Wada, K., Kusayama, T., Ishii, N., Yatsu, T., Uchida, W., Taniguchi, N., Tanaka, A. Pharmacology (2003) [Pubmed]
  3. Effect of YM471, an orally active non-peptide arginine vasopressin receptor antagonist, on human vascular smooth muscle cells. Tahara, A., Tsukada, J., Tomura, Y., Kusayama, T., Wada, K., Ishii, N., Yatsu, T., Uchida, W., Taniguchi, N., Tanaka, A. J. Hypertens. (2002) [Pubmed]
  4. Effect of YM471, a nonpeptide AVP receptor antagonist, on human coronary artery smooth muscle cells. Tahara, A., Tsukada, J., Tomura, Y., Wada, K., Kusayama, T., Ishii, N., Yatsu, T., Uchida, W., Taniguchi, N., Tanaka, A. Peptides (2002) [Pubmed]
  5. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. Tahara, A., Tsukada, J., Tomura, Y., Wada, K., Kusayama, T., Ishii, N., Yatsu, T., Uchida, W., Tanaka, A. Br. J. Pharmacol. (2000) [Pubmed]
  6. Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells. Tahara, A., Saito, M., Tsukada, J., Ishii, N., Tomura, Y., Wada, K., Kusayama, T., Yatsu, T., Uchida, W., Tanaka, A. Eur. J. Pharmacol. (1999) [Pubmed]
  7. Comparison of vasopressin binding sites in human uterine and vascular smooth muscle cells. Tahara, A., Tsukada, J., Ishii, N., Tomura, Y., Wada, K., Kusayama, T., Yatsu, T., Uchida, W., Tanaka, A. Eur. J. Pharmacol. (1999) [Pubmed]
  8. AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V1A or V1B receptors. Tahara, A., Saito, M., Sugimoto, T., Tomura, Y., Wada, K., Kusayama, T., Tsukada, J., Ishii, N., Yatsu, T., Uchida, W., Tanaka, A. Pflugers Arch. (1999) [Pubmed]
  9. Characterization of vasopressin receptor in rat lung. Tahara, A., Tomura, Y., Wada, K., Kusayama, T., Tsukada, J., Ishii, N., Yatsu, T., Uchida, W., Tanaka, A. Neuropeptides (1998) [Pubmed]
  10. Binding characteristics of YM087, an AVP receptor antagonist, in rhesus monkey liver and kidney membranes. Tahara, A., Tomura, Y., Wada, K., Kusayama, T., Tsukada, J., Ishii, N., Yatsu, T., Uchida, W., Tanaka, A. Peptides (1998) [Pubmed]
  11. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte. Tahara, A., Tomura, Y., Wada, K., Kusayama, T., Tsukada, J., Ishii, N., Yatsu, T., Uchida, W., Tanaka, A. Cardiovasc. Res. (1998) [Pubmed]
 
WikiGenes - Universities